目标温度管理
医学
自然循环恢复
复苏
观察研究
心肺复苏术
重症监护医学
临床死亡
麻醉
内科学
作者
Jerry P. Nolan,Jasmeet Soar
出处
期刊:Current Opinion in Critical Care
[Ovid Technologies (Wolters Kluwer)]
日期:2022-06-01
卷期号:28 (3): 244-249
被引量:4
标识
DOI:10.1097/mcc.0000000000000943
摘要
Purpose of review Most patients who are successfully resuscitated after cardiac arrest are initially comatose and require mechanical ventilation and other organ support in an ICU. Best practice has been to cool these patients and control their temperature at a constant value in the range of 32–36 o C for at least 24 h. But the certainty of the evidence for this practice is increasingly being challenged. This review will summarize the evidence on key aspects of temperature control in comatose postcardiac arrest patients. Recent findings The Targeted Temperature Management 2 (TTM-2) trial documented no difference in 6-month mortality among comatose postcardiac arrest patients managed at 33 o C vs. targeted normothermia. A systematic review and meta-analysis completed by the Advanced Life Support (ALS) Task Force of the International Liaison Committee on Resuscitation (ILCOR) concluded that temperature control with a target of 32–34 °C did not improve survival or favourable functional outcome after cardiac arrest. Two observational studies have documented an association between predicted moderate hypoxic–ischaemic brain injury and better outcome with temperature control at 33–34 o C compared with 35–36 o C. Summary We suggest actively preventing fever by targeting a temperature 37.5 o C or less for those patients who remain comatose following return of spontaneous circulation (ROSC) after cardiac arrest.
科研通智能强力驱动
Strongly Powered by AbleSci AI